Literature DB >> 31501979

FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins.

Mirolyuba Ilieva1,2,3,4, Troels T Nielsen5, Tanja Michel6,7,8, Stanislava Pankratova9,10.   

Abstract

In the present study, we developed an in vitro model of Huntington disease (HD) by transfecting primary rat hippocampal neurons with plasmids coding for m-htt exon 1 with different number of CAG repeats (18, 50 and 115) and demonstrated the influence of the length of polyQ sequence on neurite elongation. We found that exogenously applied FGF2 significantly rescued the m-htt-induced loss of neurite outgrowth. Moreover, the Enreptin peptide, an FGFR1 and NCAM dual agonist, had a similar neuritogenic effect to FGF2 in clinically relevant m-htt 50Q-expressing neurons. This study has developed an in vitro model of primary hippocampal neurons transfected with m-htt-coding vectors that is a powerful tool to study m-htt-related effects on neuronal placticity.

Entities:  

Keywords:  Enreptin; FGF2; Hippocampal neurons; Huntington disease; Mutant huntingtin; Neurite outgrowth

Mesh:

Substances:

Year:  2019        PMID: 31501979     DOI: 10.1007/s00702-019-02073-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  57 in total

1.  Wild-type huntingtin protects neurons from excitotoxicity.

Authors:  Blair R Leavitt; Jeremy M van Raamsdonk; Jacqueline Shehadeh; Herman Fernandes; Zoe Murphy; Rona K Graham; Cheryl L Wellington; Lynn A Raymond; Michael R Hayden
Journal:  J Neurochem       Date:  2006-01-17       Impact factor: 5.372

Review 2.  Therapeutic potential of neurotrophic factors in neurodegenerative diseases.

Authors:  Yossef S Levy; Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

3.  Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Alexandra Durr; Raymund Ac Roos; Blair R Leavitt; Rebecca Jones; G Bernhard Landwehrmeyer; Nick C Fox; Hans Johnson; Stephen L Hicks; Christopher Kennard; David Craufurd; Chris Frost; Douglas R Langbehn; Ralf Reilmann; Julie C Stout
Journal:  Lancet Neurol       Date:  2010-12-02       Impact factor: 44.182

4.  Oxidative damage and metabolic dysfunction in experimental Huntington's disease: selective vulnerability of the striatum and hippocampus.

Authors:  I D Maksimović; M D Jovanović; M Colić; R Mihajlović; D Mićić; V Selaković; M Ninković; Z Malicević; M Rusić-Stojiljković; A Jovicić
Journal:  Vojnosanit Pregl       Date:  2001 May-Jun       Impact factor: 0.168

5.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.

Authors:  J K White; W Auerbach; M P Duyao; J P Vonsattel; J F Gusella; A L Joyner; M E MacDonald
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.

Authors:  M L Maat-Schieman; J C Dorsman; M A Smoor; S Siesling; S G Van Duinen; J J Verschuuren; J T den Dunnen; G J Van Ommen; R A Roos
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

Review 7.  Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons.

Authors:  Eduardo Gascon; Laszlo Vutskits; Jozsef Zoltan Kiss
Journal:  Brain Res Rev       Date:  2007-07-04

8.  Effect of CAG repeat length on psychiatric disorders in Huntington's disease.

Authors:  Evangelos Vassos; Marios Panas; Athina Kladi; Dimitrios Vassilopoulos
Journal:  J Psychiatr Res       Date:  2007-07-03       Impact factor: 4.791

Review 9.  The Fibroblast Growth Factor signaling pathway.

Authors:  David M Ornitz; Nobuyuki Itoh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-13       Impact factor: 5.814

10.  Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease.

Authors:  Karolina Kolodziejczyk; Matthew P Parsons; Amber L Southwell; Michael R Hayden; Lynn A Raymond
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.